A carregar...
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Following the completion of the Fracture Prevention Trial, teriparatide was approved by the United States Food and Drug Administration and the European Medicine Agency as the first therapeutic anabolic agent for the treatment of postmenopausal women with severe osteoporosis. It subsequently received...
Na minha lista:
| Publicado no: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6778993/ https://ncbi.nlm.nih.gov/pubmed/31632472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X19877994 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|